Kestra Medical Technologies (NASDAQ:KMTS) Shares Up 2.5% – Still a Buy?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)’s share price was up 2.5% on Monday . The stock traded as high as $24.40 and last traded at $24.01. Approximately 80,622 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 293,426 shares. The stock had previously closed at $23.43.

Analyst Ratings Changes

KMTS has been the topic of several recent research reports. Bank of America began coverage on shares of Kestra Medical Technologies in a research note on Monday. They issued a “buy” rating and a $30.00 price objective on the stock. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research report on Monday. They set a “buy” rating and a $28.00 price objective for the company. Piper Sandler assumed coverage on shares of Kestra Medical Technologies in a report on Monday. They set an “overweight” rating and a $27.00 price target on the stock. Wolfe Research assumed coverage on shares of Kestra Medical Technologies in a research note on Monday. They issued an “outperform” rating and a $29.00 target price for the company. Finally, The Goldman Sachs Group began coverage on Kestra Medical Technologies in a research report on Monday. They issued a “neutral” rating and a $24.00 price target for the company. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, Kestra Medical Technologies has an average rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Stock Performance

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.